13 results match your criteria: "Portsmouth Hospitals National Health Service Trust[Affiliation]"
Lancet
July 2023
Centre for Cancer Immunology, University of Southampton, Southampton SO16 6YD, UK. Electronic address:
Hepatology
August 2023
CymaBay Therapeutics, Newark, California, USA.
JCI Insight
February 2023
Department of Medical and Molecular Genetics and.
J Hepatol
August 2022
CymaBay Therapeutics, Inc, Newark, California, United States.
Dis Colon Rectum
February 2021
Portsmouth Hospitals National Health Service Trust, Queen Alexandra Hospital, Hampshire, United Kingdom.
BMJ Case Rep
September 2020
Department of Breast and Endocrine Surgery, Portsmouth Hospitals NHS Trust, Portsmouth, UK.
We present this case of human herpes virus 8-positive germinotropic lymphoproliferative disorder in a 20-year-old woman seen in the surgical oncology clinic for localised lymphadenopathy. This is the first case to be reported in the UK, and we discuss it along with a literature review including investigations and treatment options. This will demonstrate the importance of preoperative workup and multidisciplinary teamwork in deciding management plans and serve as a guide for future encounters of this rare condition in clinical practice.
View Article and Find Full Text PDFLancet
December 2019
University College London Cancer Institute, and University College London Hospitals, London, UK.
Background: Carboplatin and paclitaxel administered every 3 weeks is standard-of-care first-line chemotherapy for epithelial ovarian cancer. The Japanese JGOG3016 trial showed a significant improvement in progression-free and overall survival with dose-dense weekly paclitaxel and 3-weekly carboplatin. In this study, we aimed to compare efficacy and safety of two dose-dense weekly regimens to standard 3-weekly chemotherapy in a predominantly European population with epithelial ovarian cancer.
View Article and Find Full Text PDFLancet
October 2019
The Hatter Cardiovascular Institute, University College London, London, UK. Electronic address:
Background: Remote ischaemic conditioning with transient ischaemia and reperfusion applied to the arm has been shown to reduce myocardial infarct size in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). We investigated whether remote ischaemic conditioning could reduce the incidence of cardiac death and hospitalisation for heart failure at 12 months.
Methods: We did an international investigator-initiated, prospective, single-blind, randomised controlled trial (CONDI-2/ERIC-PPCI) at 33 centres across the UK, Denmark, Spain, and Serbia.
JMIR Res Protoc
May 2017
Department of Research and Innovation, Portsmouth Hospitals National Health Service Trust, Portsmouth, United Kingdom.
Background: There are an estimated three million people in the United Kingdom with chronic obstructive pulmonary disease (COPD), and the incidence of bronchiectasis is estimated at around 0.1% but is more common in COPD and severe asthma. Both COPD and bronchiectasis are characterized by exacerbations in which bacteria play a central role.
View Article and Find Full Text PDFJAMA
August 2016
Centre for Perioperative and Critical Care Research, Imperial College Healthcare National Health Service Trust, London, United Kingdom.
Importance: Norepinephrine is currently recommended as the first-line vasopressor in septic shock; however, early vasopressin use has been proposed as an alternative.
Objective: To compare the effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock.
Design, Setting, And Participants: A factorial (2×2), double-blind, randomized clinical trial conducted in 18 general adult intensive care units in the United Kingdom between February 2013 and May 2015, enrolling adult patients who had septic shock requiring vasopressors despite fluid resuscitation within a maximum of 6 hours after the onset of shock.
J Endocrinol Invest
April 2015
Department of Paediatric Endocrinology, Portsmouth Hospitals National Health Service Trust, Portsmouth, UK.
Purpose: The IGFALS gene encodes the acid-labile subunit (ALS) protein, which regulates circulating IGF-1. Human IGFALS mutations cause growth hormone insensitivity (GHI) associated with ALS, IGF-1 and IGFBP-3 deficiencies and mild to moderate postnatal growth impairment (height SDS -2 to -4). Prenatal growth impairment is not a recognised feature of this disorder, but heterozygous carriers may show an intermediate phenotype.
View Article and Find Full Text PDFJAMA Neurol
November 2014
Department of Ophthalmology, Oxford Eye Hospital, John Radcliffe Hospital, Oxford, England.
Importance: Patients with neuromyelitis optica who have aquaporin-4 antibodies are being identified and receiving immunosuppressant treatment earlier and more aggressively as a result of increasing awareness of the importance of preventing relapses responsible for the high morbidity and mortality associated with the disease. To our knowledge, opportunistic retinal infection in patients with aquaporin-4 antibodies who are receiving immunosuppressants has not been reported to date.
Observations: We describe 2 patients with aquaporin-4 antibodies who were receiving conventional doses of first-line immunosuppressive therapy.
J Appl Physiol (1985)
June 2006
Institute of Biomedical and Biomolecular Sciences, Department of Sport and Exercise Science, St. Michael's Bldg., University of Portsmouth, White Swan Road, and Portsmouth Hospitals National Health Service Trust, UK PO1 2DT.
The ventilatory responses to immersion and changes in temperature are reviewed. A fall in skin temperature elicits a powerful cardiorespiratory response, termed "cold shock," comprising an initial gasp, hypertension, and hyperventilation despite a profound hypocapnia. The physiology and neural pathways of this are examined with data from original studies.
View Article and Find Full Text PDF